Team:KIT-Kyoto/kazukokekokko
From 2012.igem.org
(Difference between revisions)
Line 65: | Line 65: | ||
<div class="category"><img src="https://static.igem.org/mediawiki/2012/1/1f/Side_labnotekit.jpg" width="150" height="30"></div> | <div class="category"><img src="https://static.igem.org/mediawiki/2012/1/1f/Side_labnotekit.jpg" width="150" height="30"></div> | ||
<ul class="menu"> | <ul class="menu"> | ||
- | <li><a href="https://2012.igem.org/Team:KIT-Kyoto/Notebook- | + | <li><a href="https://2012.igem.org/Team:KIT-Kyoto/Notebook-week1p"><img src="https://static.igem.org/mediawiki/2012/1/1b/Side_week1kit.jpg" width="150" height="30"></a></li> |
- | <li><a href="https://2012.igem.org/Team:KIT-Kyoto/Notebook- | + | <li><a href="https://2012.igem.org/Team:KIT-Kyoto/Notebook-week2p"><img src="https://static.igem.org/mediawiki/2012/9/94/Side_week2kit.jpg" width="150" height="30"></a></li> |
- | <li><a href="https://2012.igem.org/Team:KIT-Kyoto/Notebook- | + | <li><a href="https://2012.igem.org/Team:KIT-Kyoto/Notebook-week3p"><img src="https://static.igem.org/mediawiki/2012/e/e0/Side_week3kit.jpg" width="150" height="30"></a></li> |
- | <li><a href="https://2012.igem.org/Team:KIT-Kyoto/Notebook- | + | <li><a href="https://2012.igem.org/Team:KIT-Kyoto/Notebook-week4p"><img src="https://static.igem.org/mediawiki/2012/3/31/Side_week4kit.jpg" width="150" height="30"></a></li> |
- | <li><a href="https://2012.igem.org/Team:KIT-Kyoto/Notebook- | + | <li><a href="https://2012.igem.org/Team:KIT-Kyoto/Notebook-week5p"><img src="https://static.igem.org/mediawiki/2012/e/e7/Side_week5kit.jpg" width="150" height="30"></a></li> |
- | <li><a href="https://2012.igem.org/Team:KIT-Kyoto/Notebook- | + | <li><a href="https://2012.igem.org/Team:KIT-Kyoto/Notebook-week6p"><img src="https://static.igem.org/mediawiki/2012/e/e8/Side_week6kit.jpg" width="150" height="30"></a></li> |
- | + | ||
</ul> | </ul> | ||
</li> | </li> |
Revision as of 09:48, 25 September 2012
TNFAIP3
PARTS BP reaction by Invitrogen gateway system1. PCR using primers containing the attB sequence. 2. Purify PCR product. 3. Add the following components to a 1.5 mL microcentrifuge tube at room temperature and mix:
4. Vortex BP ClonaseII enzyme mix briefly. Add 1 - 2 μL to the components above and mix well by vortexing and spin them down. 5. Incubate reaction at 25˚C for more than 1 hour. 6. Add 1 μL of 2 μg/μL Proteinase K solution and vortex briefly. 7. Incubate at 37˚C for 10 minutes. LR reaction by Invitrogen gateway system1. Add the following components to a 1.5 mL microcentrifuge tube at room temperature and mix:
2. Vortex LR ClonaseII enzyme mix briefly. Add 1 – 2 μL, to the components above and mix well by vortexing and spin down. 3. Incubate reaction at 25˚C for 16 hours. 4. Add 1 μL of 2 μg/μL Proteinase K solution and vortex briefly. 5. Incubate at 37˚C for 10 minutes. |
|||||||||||||